MAb PGT121 protects against mucosal SHIV challenge in macaques at concentrations corresponding to its highly potent in vitro neutralization capacity

by Moldt, B, Rakasz, EG, Schultz, N, Chan-Hui, P, Swiderek, K, Watkins, DI, Burton, DR, Poignard, P
Published 2012

Recognition and penetration of the HIV-1 Env glycan shield by potent broadly neutralizing antibodies

by Julien, J, Kong, L, Pejchal, R, Khayat, R, Lee, J, Stanfield, RS, Walker, LM, Doores, KJ, Folkowska, E, Poignard, P, Depetris, R, Sanders, RW, Koff, WC, Moore, JP, Ward, AB, Burton, DR, Wilson, IA
Published 2012

Engineered mice and B cell lines expressing broadly neutralizing antibodies and their unmutated precursors: tools for HIV vaccinology

by Nemazee, D, Doyle-Cooper, C, Ota, T, Cooper, AB, Huber, M, Falkowska, E, Doores, K, Hangartner, L, Le, K, Sok, D, Jardine, J, Lifson, J, Wu, X, Mascola, JR, Poignard, P, Binley, JM, Chakrabarti, BK, Schief, WR, Wyatt, RT, Burton, DR
Published 2012

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses

by Hoffenberg, S, Pond, S Kosakovsky, Carpov, A, Wagner, D, Wilson, A, Powell, R, Lindsay, R, Arendt, H, DeStefano, J, Poignard, P, Simek, M, Fling, S, Phogat, S, Labranche, C, Montefiori, D, Burton, D, Parks, C, King, C, Koff, W, Caulfield, M
Published 2012